Octreotide Injection, Solution
Product Images NDC 63323-379

10 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Octreotide (NDC 63323-379). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Oct03 0005 01)

Structural Formula (Oct03 0005 01)
Chemical structure diagram showing the peptide sequence of Octreotide Acetate, a synthetic octapeptide. The structure highlights individual amino acids and their sequence in the molecule.*
FDA Label Image

Logo (Oct03 0005 02)

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Label for Octreotide Acetate Injection, 100 mcg per mL, a single dose vial for subcutaneous or intravenous use. The label indicates the product is preservative free and should be protected from light. It is labeled for Rx only and distributed by Fresenius Kabi USA, LLC. The NDC number 63323-376-00 is visible along with a barcode.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Label for Octreotide Acetate Injection at 100 mcg per mL strength, intended for subcutaneous or intravenous use. The package contains 10 single-dose vials of 1 mL each. The product is preservative-free and labeled by Fresenius Kabi USA, LLC, Lake Zurich, IL. Storage instructions note refrigeration and stability details.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Label for Octreotide Acetate Injection showing 500 mcg per mL strength. It is indicated for subcutaneous or intravenous use, preservative free, and requires protection from light. The vial is 1 mL single-dose, labeled for prescription use only. The labeler is Fresenius Kabi USA, LLC.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Label for Octreotide Acetate Injection 500 mcg/mL, a preservative-free solution for subcutaneous or intravenous use. The package contains 10 single-dose 1 mL vials. The label includes storage instructions and lists inactive ingredients. The product is manufactured by Fresenius Kabi USA, LLC in Lake Zurich, IL.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Octreotide Acetate Injection label for 1,000 mcg per 5 mL (200 mcg per mL) multiple dose vial. It is intended for subcutaneous or intravenous use. The label lists active and inactive ingredients, storage instructions to refrigerate at 2°C to 8°C and protect from light, and states it is Rx only. The labeler is Fresenius Kabi USA, LLC.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
This image shows multiple labels for Octreotide Acetate Injection, 1,000 mcg per 5 mL (200 mcg per mL) by Fresenius Kabi USA, LLC. The labels display the product name, strength, dosage form, bar code, storage instructions, and composition details for a 5 mL multiple dose vial intended for subcutaneous or intravenous use. Storage guidelines specify refrigeration at 2°C to 8°C and protection from light, with disposal instructions after initial use within 14 days.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Label for Octreotide Acetate Injection, 1000 mcg/mL (5,000 mcg per 5 mL), supplied as a 5 mL multiple dose vial. The label indicates use for subcutaneous or intravenous administration, and is manufactured by Fresenius Kabi USA, LLC. Storage instructions specify refrigeration at 2°C to 8°C and protection from light.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Label for Octreotide Acetate Injection 5000 mcg per 5 mL (1000 mcg per mL) by Fresenius Kabi USA, LLC. The label indicates a 5 mL multiple dose vial. It notes the drug is for subcutaneous or intravenous use, sterile, and lists key inactive ingredients. Storage instructions specify refrigeration at 26 to 86C and protection from light, with discard within 14 days after opening. The label includes the NDC 63323-379-05 and the Fresenius Kabi logo and address.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.